Clincosm LogoSign in Get a demo

Waldenstrom Macroglobulinemia

Showing NaN - NaN of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma Trial in Australia, United States (BGB-16673)

Recruiting
  • B-cell Malignancy
  • +8 more
  • Phoenix, Arizona
  • +14 more
Jan 17, 2023

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +13 more
Jan 12, 2023

Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • Iopofosine I 131 single dose
  • +2 more
  • Redlands, California
  • +42 more
Dec 30, 2022

Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston

Recruiting
  • Mantle Cell Lymphoma
  • +9 more
  • L-Bcl-2 antisense oligonucleotide
  • Augusta, Georgia
  • +2 more
Nov 18, 2022

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Lymphocytic, Small, Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib)

Available
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +4 more
  • Stanford, California
  • +61 more
Aug 17, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Chronic Lymphocytic Leukemia
  • +6 more
  • Duarte, California
  • +165 more
Mar 24, 2022

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +35 more
  • Akt inhibitor MK2206
  • laboratory biomarker analysis
  • Houston, Texas
    M D Anderson Cancer Center
Oct 14, 2020

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma Trial in United States (SNS-062)

Terminated
  • Chronic Lymphocytic Leukemia
  • +7 more
  • Orange, California
  • +10 more
Oct 15, 2020

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

Completed
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • +9 more
  • Stanford, California
  • +15 more
May 14, 2020

B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia Trial in United States (AVL-292)

Completed
  • B Cell Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +12 more
Nov 6, 2019

Waldenstrom Macroglobulinemia Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

Withdrawn
  • Waldenstrom Macroglobulinemia
  • Antineoplaston therapy (Atengenal + Astugenal)
  • Houston, Texas
    Burzynski Clinic
Feb 1, 2018

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +45 more
  • anti-endosialin/TEM1 monoclonal antibody MORAb-004
  • +2 more
  • Birmingham, Alabama
  • +19 more
Jan 7, 2016

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Houston (recombinant

Completed
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +16 more
  • recombinant interleukin-12
  • laboratory biomarker analysis
  • Houston, Texas
    M D Anderson Cancer Center
Apr 14, 2015

Cutaneous B-cell Non-Hodgkin Lymphoma, MALT, Intraocular Lymphoma Trial in Houston (oblimersen sodium, rituximab, laboratory

Completed
Has Results
  • Cutaneous B-cell Non-Hodgkin Lymphoma
  • +20 more
  • oblimersen sodium
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 13, 2014

Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +50 more
  • Akt inhibitor MK2206
  • +2 more
  • Birmingham, Alabama
  • +24 more
Apr 28, 2014

Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

Completed
  • Adult Grade III Lymphomatoid Granulomatosis
  • +61 more
  • bevacizumab
  • cediranib maleate
  • Houston, Texas
    M D Anderson Cancer Center
Feb 14, 2014

Angioimmunoblastic T-cell Lymphoma, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Houston (nelarabine)

Terminated
  • Angioimmunoblastic T-cell Lymphoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 22, 2013

Angioimmunoblastic T-cell Lymphoma, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Houston (oxaliplatin)

Completed
  • Angioimmunoblastic T-cell Lymphoma
  • +16 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 22, 2013